Plans for a Phase 2b clinical trial that will test CS1, Cereno Scientific‘s experimental treatment for pulmonary arterial…
Articles by Marisa Wexler, MS
Most people with pulmonary arterial hypertension (PAH) who were treated with Uptravi (selexipag) and followed up for 10…
The first participant has been dosed in a Phase 2 trial testing the experimental oral therapy mirivadelgat in people with…
Synhale Therapeutics has acquired the rights to the experimental therapy telaglenastat (CB-839), which has previously been tested as a potential…
The PAH Initiative is hosting a video event in May to provide information about the benefits of exercise for…
The advocacy organization Phaware is launching a series of podcasts to explore new advances in the treatment of…
Treatment with the approved therapy Winrevair (sotatercept-csrk) significantly reduced the risk of death, lung transplant, or hospitalization in people…
The U.S. Food and Drug Administration (FDA) is poised to soon issue a final determination on Yutrepia, an inhaled dry…
People with coarctation of aorta, or COA — a condition marked by narrowing where the body’s largest blood vessel connects…
Merck announced that its Phase 3 clinical trial HYPERION, which had been testing Winrevair (sotatercept-csrk) in people with…
An imaging technique called 18F-FAPI PET may be able to detect the earliest signs of changes in blood vessel tissues…
Using in-depth analyses and machine learning, scientists have identified several molecules and genes involved in metabolism that may be diagnostic…